English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Pharma & Biotech Healthcare & Pharm
Agilex Biolabs Develops World's Most Accurate Cannabinoid Assay
Sep 23, 2020 12:00 HKT
Avance Clinical Announces Expanded eClinical Solutions for Biotech Clinical Trials at BioPharm America
Sep 22, 2020 07:50 HKT
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance
Sep 18, 2020 17:00 HKT
Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development
Sep 17, 2020 20:30 HKT
NanoViricides Nominates a Novel Candidate for Advancing Into Clinical Trials for Treatment of COVID-19
Sep 16, 2020 18:15 HKT
Huge chance to innovate as online medical services take root, Platform makes name for itself in disease management during pandemic
Sep 07, 2020 13:40 HKT
Avance Clinical Client Immunic, Inc. Announced Dosing of First Healthy Volunteer in Phase 1 Clinical Program of IMU-856, Targeting Restoration of Intestinal Barrier Function
Sep 04, 2020 13:00 HKT
Regent Pacific enters longevity medicine business driven by leading AI technology through acquisition of Deep Longevity, Inc.
Sep 02, 2020 21:21 HKT
Moms on Watch Condemns Lack of Diversity at Prolacta; Demands Prolacta's Leadership Team Reflect the Communities it Serves
Sep 02, 2020 15:00 HKT
AI Startup Deep Longevity Launches with Series A Financing and New AI System to Tackle Aging-Related Diseases
Sep 02, 2020 08:55 HKT
Jacobson Pharma Collaborates with Fosun Pharma Group to Supply Potentially 10 Million Doses of BioNTech SE's COVID-19 Vaccine Candidate in Hong Kong and Macau
Aug 27, 2020 20:40 HKT
Lee's Pharm Announces 2020 Interim Results
Aug 27, 2020 20:00 HKT
Universal Medical Announced its 2020 Interim Results
Aug 26, 2020 14:00 HKT
Novotech the Asia-Pacific CRO Leader - Awarded '2020 Frost & Sullivan Asia-Pacific CRO Company of the Year'
Aug 26, 2020 10:00 HKT
Sihuan Pharmaceutical Announces 2020 Interim Results
Aug 25, 2020 21:26 HKT
INDONESIA: BUMN Go Global is the Accurate Strategy in Midst of Pandemic
Aug 21, 2020 11:00 HKT
Ivermectin Triple Therapy Protocol for COVID-19 Released to Australian GPs for Infected Elderly and Frontline Workers
Aug 20, 2020 10:00 HKT
Bayer and Hua Medicine announce commercialization agreement and strategic partnership for investigational first-in-class novel diabetes treatment dorzagliatin in China
Aug 17, 2020 19:20 HKT
QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma
Aug 13, 2020 15:30 HKT
China Medical System Holdings Limited 2020 Interim Results Announcement
Aug 13, 2020 08:55 HKT
<< Previous  Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: